Diabetologie und Stoffwechsel 2021; 16(04): 321
DOI: 10.1055/s-0041-1730854
Late-Breaking-Abstract

Diabetes mellitus leads to an impaired reverse migration capacity of CD14++ monocytes causing a subluminal accumulation

D Semo
1   Universitätsklinikum Münster, Molecular Cardiology, Department of Cardiology I – Coronary and Peripheral Vascular Disease, Heart Failure, Münster, Germany
,
S Adama
2   University of Geneva, Department of Pathology and Immunology, Geneva, Switzerland
,
SK Shanmuganathan
3   Universitätsklinikum Münster, Cells-in-Motion Cluster of Excellence (EXC 1003—CiM), Münster, Germany
,
N Müller
4   Universitätsklinikum Jena, Klinik für Innere Medizin III, Department of Internal Medicine III, Jena, Germany
,
UA Müller
4   Universitätsklinikum Jena, Klinik für Innere Medizin III, Department of Internal Medicine III, Jena, Germany
,
FD Böhmer
5   Universitätsklinikum Jena, Institute of Molecular Cell Biology, Center for Molecular Biomedicine, Jena,Germany
,
BA Imhof
2   University of Geneva, Department of Pathology and Immunology, Geneva, Switzerland
,
R Godfrey
1   Universitätsklinikum Münster, Molecular Cardiology, Department of Cardiology I – Coronary and Peripheral Vascular Disease, Heart Failure, Münster, Germany
,
J Waltenberger
6   Westfälische Wilhelms-Universität Münster, Medizinische Fakultät Münster, Münster, Germany
› Author Affiliations
 
 

    Atherosclerosis as a chronic inflammation is driven by multiple cardiovascular risk factors, such as diabetes mellitus (DM). Monocytes represent the biggest cell population in the atherosclerotic aorta. DM induces oxidative stress, which causes a monocytic dysfunction. Albeit it is known that DM leads to an monocytic accumulation within the inflammatory tissue and induces plaque formation, it remains unclear which mechanisms drive the accumulation in diabetic environment. To investigate the DM induced changes in monocytic diapedesis in vitro a flow assay model was established. CD14++ monocytes of patients, who either suffered from type 2 diabetes mellitus (T2DM) or not (nonDM), were isolated. Besides CD14++ monocytes, isolated from healthy donors, were conditioned in normo- or hyperglycemic evironment. An endothelial monolayer was activated and then perfused with the monocytes. The experiments were performed under physiological flow conditions that can be found in postcapillary venules. The data was analysed by single cell tracking using the Fiji J software. In this project, we could prove a significant reduced transendothelial migration capacity of T2DM- and hyperglycemia-conditioned monocytes. An extended stay of monocytes in the albumen after transendothelial migration was revealed. Moreover, the capacity of the monocytes to undergo reverse migration was reduced and lead to an accumulation after transendothelial migration. This suggests, that the enhanced monocytic accumulation in DM could be associated with a dysfunctional reverse transendothelial migration and is not due to a quantitatively enhanced diapedesis. We indicate that restoring the impaired reverse migration could reduce the accumulation of monocytes and atherogenesis within diabetic environment.


    #

    Interessenskonflikt

    Es bestehen keine Interessenskonflikte.

    Publication History

    Article published online:
    19 August 2021

    © 2021. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany